Instilación intrapleural de activador tisular de plasminógeno y de deoxirribonucleasa recombinante humana en el empiema pleural. Visits. Download PDF. Se colocó un catéter en el extremo aórtico de la fístula y se instauró, a su través, tratamiento con activador recombinante tisular del plasminógeno (r-TPA) en. activator in vascular warning syndromesTrombólisis intravenosa con activador tisular del plasminógeno recombinante en los síndromes de alarma vascular☆.
|Published (Last):||13 March 2016|
|PDF File Size:||5.18 Mb|
|ePub File Size:||9.86 Mb|
|Price:||Free* [*Free Regsitration Required]|
Previous article Next article.
To improve our services and products, we use “cookies” own or third parties authorized to show advertising related to client preferences through the analyses of navigation customer behavior. Nine issues are published each year, including mostly originals, reviews and consensus documents. The journal fully endorses the goals of updating knowledge and facilitating the acquisition of key developments in internal medicine applied to clinical practice.
Thrombolysis with recombinant tissue plasminogen activator rTPA has been used as an alternative to heparin in life threatening giant thrombus and embolization. They received between 1 to 5 cycles with rTPA.
From Monday to Friday from 9 a. Intracardiac thrombi; Neonatal thrombolysis; Recombinant tissue plasminogen activator. The superior vena cava was the most frequent location, with a mean time of installation before the diagnosis of 12 days.
The incidence of cardiac thrombi in newborns has increased with the use of central venous catheters. SJR uses a similar algorithm tisuoar the Google page rank; it provides a quantitative and qualitative measure of the journal’s impact. SRJ is a prestige metric based on the idea that not all citations are the same.
Activador del plasminógeno tisular recombinante en el manejo de trombos cardiacos en recién nacidos
Are you a health professional able to prescribe or dispense drugs? Four patients had intracranial haemorrhage grade I, without sequelae at follow-up. This item has received. March Pages ee24 Pages In 4 patients complete resolution of the thrombus was achieved in a mean of 3.
Subscriber If you already have your login data, please click here. Recombinant tissue recokbinante activator for the management of intracardiac thrombi in newborns.
There was a problem providing the content you requested
Subscribe to our Newsletter. The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the plasmnogeno receding years. SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field. You can change the settings or obtain more information by clicking here. The medical records of 8 newborn were reviewed in a retrospective study, of whom 7 were preterm with cardiac thrombi, and rTPA was used in all of them.
CiteScore measures average citations received per document published. Continuing navigation will be considered as acceptance of this use. Si continua navegando, consideramos que acepta su uso.
There were no deaths or embolism. The aim of this study is plasminobeno describe the response and complications related to the use of rTPA in the management of life- threatening cardiac thrombi in newborns. Three patients received low molecular weight heparin prior to using rTPA. The patients included 4 males with a mean weight of gr. Print Send to a friend Export reference Mendeley Statistics.